TORMENE, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.789
EU - Europa 830
AS - Asia 691
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
AF - Africa 1
Totale 9.324
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.785
CN - Cina 325
SG - Singapore 303
FI - Finlandia 175
DE - Germania 133
UA - Ucraina 124
SE - Svezia 117
IT - Italia 109
FR - Francia 83
GB - Regno Unito 57
VN - Vietnam 29
IE - Irlanda 13
IN - India 8
NL - Olanda 8
HK - Hong Kong 7
JP - Giappone 6
CA - Canada 4
PH - Filippine 4
TW - Taiwan 4
CZ - Repubblica Ceca 3
EU - Europa 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
BR - Brasile 2
SA - Arabia Saudita 2
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
EE - Estonia 1
GR - Grecia 1
IQ - Iraq 1
IR - Iran 1
KG - Kirghizistan 1
LT - Lituania 1
NO - Norvegia 1
PL - Polonia 1
RO - Romania 1
ZA - Sudafrica 1
Totale 9.324
Salva come PNG Salva come JPEG
Città #
Fairfield 1.284
Woodbridge 869
Jacksonville 595
Ann Arbor 567
Houston 523
Ashburn 521
Chandler 518
Seattle 461
Wilmington 445
Cambridge 394
Singapore 238
Princeton 226
Boardman 204
San Diego 117
Roxbury 105
Des Moines 89
Beijing 82
Santa Clara 78
Nanjing 71
Helsinki 68
Medford 61
Padova 31
Dong Ket 29
Nanchang 25
Shenyang 22
Jiaxing 19
Hebei 18
Norwalk 18
London 17
Changsha 13
New York 13
Tianjin 10
Los Angeles 9
Redwood City 9
Dublin 8
Chicago 7
Indiana 7
Ferentino 6
Kharkiv 6
Legnaro 6
Chiswick 5
Milan 5
Muenster 5
Hong Kong 4
Jinan 4
Naples 4
Taipei 4
Caracas 3
Civitanova Marche 3
Guangzhou 3
Mestre 3
Ogden 3
Orange 3
Redmond 3
Shanghai 3
Tappahannock 3
Bassano Del Grappa 2
Blackburn 2
Borås 2
Cork 2
Dallas 2
Falls Church 2
Geislingen an der Steige 2
Gurgaon 2
Haikou 2
Honkomagome 2
Hounslow 2
Kai Yi Wan 2
Kilburn 2
Marburg 2
Munich 2
Ningbo 2
Nuraminis 2
Prescot 2
Riyadh 2
Rome 2
San Giovanni la Punta 2
Tokyo 2
Washington 2
Yellow Springs 2
Zhengzhou 2
Acton 1
Adliswil 1
Aigaleo 1
Andover 1
Asir 1
Auburn Hills 1
Austin 1
Baghdad 1
Baltimore 1
Bethesda 1
Bishkek 1
Boston 1
Boydton 1
Brierley Hill 1
Brno 1
Buffalo 1
Buji 1
Cebu City 1
Clifton 1
Totale 7.916
Salva come PNG Salva come JPEG
Nome #
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score 154
Abnormal propeptide processing resulting in the presence of two abnormal species of protein C in plasma - Characterization of the dysfunctional protein C Padua(3) (Protein CR-1L/propeptide) 140
Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia 126
null 122
X-linked thrombophilia with a mutant factor IX (factor IX Padua). 122
The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort study 118
Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S 117
Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis. 112
New prothrombin mutation (Arg596Trp, Prothrombin Padua 2) associated with venous thromboembolism 107
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies 107
Sudden hearing loss followed by deep vein thrombosis and pulmonary embolism in a patient with factor V Leiden mutation. 104
"Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. 103
The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation. 103
Aspirin for preventing the recurrence of venous thromboembolism. 101
Similar hypercoagulable state and thrombosis risk in type I and type III proteinS-deficient individuals from mixed type I/III families. 101
The Risk of Cancer Progression in Women With Gynecological Malignancies and Thrombophilic Polymorphisms: A Pilot Case-Control Study. 100
Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant. 100
Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants 99
Alterations in the coagulation profile in renal pig-to-monkey xenotransplantation 99
Naturally occurring Arg-1 to Leu mutation in human protein C (protein C Padua(3)) resulting in an abnormal propeptide processing and in a molecule with discrepant functional activities 98
Factor V Leiden is associated with more distal location of deep vein thrombosis of the leg. 97
Pitfalls of protein C assays in patients with activated protein C resistance 96
Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean area 96
Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes. 96
Peculiar laboratory phenotype/ genotype relationship due to compound inherited protein C defects in a child with severe venous thromboembolism 95
Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian family 94
Sex-related type of venous thromboembolism in patients with and without thrombophilia. 93
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. 92
Obstetric complications and pregnancy-related venous thromboembolism: the effect of low molecular weight heparin on their prevention in carriers of factor V leiden or prothrombin G20210A mutation 90
Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis. 90
The G20210A prothrombin variant and the risk of venous thromboembolism or fetal loss in pregnant women: a family study. 89
Effects of long-term administration of high-dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts 89
Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma. 88
Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet-derived cofactor 88
Thrombophilia as a predictor of persistent residual vein thrombosis 87
Idraparinux: review of its clinical efficacy and safety for prevention andtreatment of thromboembolic disorders. 86
An underestimated combination of opposites resulting in enhanced thrombotic tendency 86
Similar hypercoagulable state and thrombosis risk in type Iand type III protein S-deficient individuals from families with mixed type I/IIIprotein S deficiency. 85
Thrombosis and thrombophilia in children: a systematic review. 85
Diagnosis of recurrent deep vein thrombosis. 84
Inherited thrombophilia and venous thromboembolism 84
APC resistance, oral contraceptive therapy and deep vein thrombosis: settled and unsettled problems 84
Factor V Leiden pseudo-homozygotes have a more pronounced hypercoagulable state than factor V Leiden homozygotes. 83
Factor V Leiden paradox and the occurrence of distal vein thrombosis in a large cohort of thrombotic patients 83
Differential effects of high prothrombin levels on thrombin generation depending on the cause of the hyperprothrombinemia. 82
Recurrent thromboembolism in fertile women with venous thrombosis: incidence and risk factors 82
Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants. 81
The risk of fetal loss in family members of probands with factor V Leiden 80
Duration of anticoagulation and risk of recurrent thromboembolism in carriers of factor V Leiden or prothrombin mutation 80
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family 79
Asymptomatic homozygous nt 20210 G to A prothrombin polymorphism in two blood donors belonging to two different kindreds 79
Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial 78
Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. 78
ProC global: a new automated screening assay for the evaluation of total function of the protein C system 77
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients 77
It is not sure yet whether the nt 20210 G to A prothrombin polymorphism represents a cause of familial venous thrombophilia. 77
Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma 75
Pregnancy-related recurrent events in thrombophilic women with previous venous thromboembolism 75
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 74
Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations 73
Immobilization resulting from chronic medical diseases: a new risk factor for recurrent venous thromboembolism in anticoagulated patients 73
The Risk of Cancer Progression in Women With Gynecological Malignancies andThrombophilic Polymorphisms: A Pilot Case-Control Study. 73
The effect of pre-eclampsia on the levels of coagulation and fibrinolysis factors in umbilical cord blood of newborns 72
Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). 72
Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation 72
Factor V variants, activated protein C resistance and venous thromboembolism. 70
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study 70
Effect of prothrombin 19911 A>G polymorphism on the risk of cerebralsinus-venous thrombosis. 69
Prothrombotic activity of oral contraceptives in patients with congenital thrombophilia varies with the defect. . 68
Two additional homozygous patients for the 20210 prothrombin polymorphism with no venous thrombosis inverted question markletter 67
Long term use of oral contraceptives without thrombosis in patients with FV Leiden polymorphism: a study of 37 patients (2 homozygous and 35 heterozygous). 67
Factor V Leiden is associated with more distal location of deep vein thrombosis of the leg. 66
The G20210A prothrombin variant and the risk of venous thromboembolism or fetal loss in pregnant women: a family study. J Thromb Haemost. 2007 Nov;5(11):2193-6. 66
Long-term use of oral contraceptive therapy in women with the prothrombin 20210 G-A polymorphism without thrombotic complications: a study of 13 women (12 heterozygotes and 1 homozygote) 65
Incidence of VTE in asymptomatic children with deficiencies of antithrombin, protein C, and protein S: a prospective cohort study 65
The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study 64
The G20210A prothrombin gene mutation: is there room for screening families? 63
Heterozygous carrier of G20210A prothrombin mutation used oral contraceptive treatment for 23 years without thrombotic events, and developed cerebral venous thrombosis 1 month after resumption of the medication at the age of 50 63
Thrombophilic screening in young patients (< 40 years) with idiopathic ischemic stroke: a controlled study. 63
Venous thromboembolism, fetal loss and preeclampsia in pregnant women with congenital thrombophilia 62
Screening for thrombophilia in children: a puzzling decision with unclear implications. 62
Risk of subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis 62
P.28 Factor V Leiden, PT-G20210A, MTHFR C677T mutations and the risk of implantation failure in women undergoing assisted reproductive procedures (IVF or ICSI) 62
Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism 62
The incidence of venous thromboembolism in asymptomatic carriers of antithrombin, protein C or protein S: a prospective cohort study. 61
Seasonal variation in the incidence of deep vein thrombosis in patients with deficiency of protein C or protein S 61
Early cerebral sinovenous thrombosis in a child with acute lymphoblastic leukemia carrying the prothrombin G20210A variant: a case report and review of the literature. 61
Homozygous patients with the 20210 G to A prothrombin polymorphism remain often asymptomatic in spite of the presence of associated risk factors. 61
Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis 61
High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial 61
FV Leiden pseudo-homozygotes have a more pronounced hypercoagulable state than FV Leiden homozygotes. 60
Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study 60
Incidence of venous thromboembolism in families with inherited thrombophilia 60
Below-knee elastic compression stockings to prevent the post-thromboric syndrome. 59
Hyperhomocysteinemia and deep-vein thrombosis. A case-control study. 59
Influence of single nucleotide polymorphisms on thrombin generation in factor V Leiden heterozygotes. 59
D-dimer as an adjunct to compression ultrasonography in patients with suspected recurrent deep vein thrombosis 58
Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms. 58
Thrombophilic screening in young patients ( 56
. Isolation and characterization of an antifactor V antibody causing APC resistance from a patient with severe thrombotic manifestations 56
Totale 8.169
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.993
article - articoli 32.081
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.074
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.448 0 0 0 0 204 174 179 244 241 201 76 129
2020/20211.524 51 165 14 169 78 129 49 153 185 210 195 126
2021/20221.525 42 161 120 102 111 107 30 162 117 36 138 399
2022/20231.065 261 108 36 106 175 145 3 68 96 6 40 21
2023/2024481 18 92 51 42 28 33 22 16 13 20 78 68
2024/2025735 8 189 160 72 306 0 0 0 0 0 0 0
Totale 9.386